Professor Testifies He Tipped Ex-SAC Manager Martoma

Law360, New York (January 17, 2014, 6:40 PM EST) -- Mathew Martoma received confidential details about an Alzheimer’s drug study from a then-University of Michigan professor, the professor testified Friday in Manhattan federal court in the insider trading case against the ex-SAC Capital Advisors LP portfolio manager.

Sidney Gilman, who chaired a safety committee overseeing trials on the experimental drug bapineuzumab, said he provided Martoma with information about the drug ahead of a July 2008 conference in which he announced the study results.

“I revealed information that was confidential about a clinical drug trial to Mathew...
To view the full article, register now.